12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
This study has been terminated.
(Lack of efficacy identified during a preliminary analysis)
Sponsor:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01362348
First received: May 19, 2011
Last updated: January 4, 2013
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2012 |
| Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | October 4, 2012 |